These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 11434771

  • 21. Irreversible binding of cis-(+)-3-methylfentanyl isothiocyanate to the delta opioid receptor and determination of its binding domain.
    Zhu J, Yin J, Law PY, Claude PA, Rice KC, Evans CJ, Chen C, Yu L, Liu-Chen LY.
    J Biol Chem; 1996 Jan 19; 271(3):1430-4. PubMed ID: 8576134
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Changes in the binding characteristics of the mu, delta and kappa subtypes of the opioid receptor in the hypothalamus of the normal cyclic ewe and in the ovariectomised ewe following treatment with ovarian steroids.
    Thom B, Canny BJ, Cowley M, Wright PJ, Clarke IJ.
    J Endocrinol; 1996 Jun 19; 149(3):509-18. PubMed ID: 8691110
    [Abstract] [Full Text] [Related]

  • 26. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor.
    Xue JC, Chen C, Zhu J, Kunapuli S, DeRiel JK, Yu L, Liu-Chen LY.
    J Biol Chem; 1994 Dec 02; 269(48):30195-9. PubMed ID: 7982926
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
    Hjorth SA, Thirstrup K, Schwartz TW.
    Mol Pharmacol; 1996 Oct 02; 50(4):977-84. PubMed ID: 8863844
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor.
    Claude-Geppert PA, Liu J, Solberg J, Erickson-Herbrandson LJ, Loh HH, Law PY.
    J Pharmacol Exp Ther; 2005 Apr 02; 313(1):216-26. PubMed ID: 15579496
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
    Gackenheimer SL, Suter TM, Pintar JE, Quimby SJ, Wheeler WJ, Mitch CH, Gehlert DR, Statnick MA.
    Neuropeptides; 2005 Dec 02; 39(6):559-67. PubMed ID: 16289278
    [Abstract] [Full Text] [Related]

  • 38. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML, Mendelsohn LG, Mitch CH, Zimmerman DM.
    Receptor; 1994 Dec 02; 4(1):43-53. PubMed ID: 8038706
    [Abstract] [Full Text] [Related]

  • 39. Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
    Zhang P, Johnson PS, Zöllner C, Wang W, Wang Z, Montes AE, Seidleck BK, Blaschak CJ, Surratt CK.
    Brain Res Mol Brain Res; 1999 Oct 01; 72(2):195-204. PubMed ID: 10529478
    [Abstract] [Full Text] [Related]

  • 40. Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
    Hjorth SA, Thirstrup K, Grandy DK, Schwartz TW.
    Mol Pharmacol; 1995 Jun 01; 47(6):1089-94. PubMed ID: 7541509
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.